Voloridge Investment Management
GMAB icon

Voloridge Investment Management’s Genmab GMAB Stock Holding History

Voloridge Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,302
Closed -$2.6M – 1110
2025
Q4 		$2.6M Sell
84,302
-46,513
-36% -$1.45M 0.01% 880
2025
Q3 		$4.01M Sell
130,815
-818,363
-86% -$19.9M 0.01% 796
2025
Q2 		$19.6M Sell
949,178
-364,107
-28% -$7.47M 0.07% 327
2025
Q1 		$25.7M Buy
1,313,285
+203,094
+18% +$4.26M 0.1% 283
2024
Q4 		$23.2M Buy
1,110,191
+561,767
+102% +$12.3M 0.08% 311
2024
Q3 		$13.4M Buy
548,424
+20,195
+4% +$540K 0.05% 492
2024
Q2 		$13.3M Buy
528,229
+121,549
+30% +$3.45M 0.05% 495
2024
Q1 		$12.2M Buy
406,680
+271,230
+200% +$7.97M 0.04% 438
2023
Q4 		$4.31M Buy
+135,450
New +$4.25M 0.02% 659
2023
Q3 		– Sell
-61,055
Closed -$2.32M – 1471
2023
Q2 		$2.32M Sell
61,055
-121,772
-67% -$4.85M 0.01% 941
2023
Q1 		$6.9M Buy
182,827
+90,113
+97% +$3.46M 0.03% 567
2022
Q4 		$3.93M Buy
+92,714
New +$3.82M 0.02% 739
2022
Q3 		– Sell
-45,257
Closed -$1.47M – 1477
2022
Q2 		$1.47M Sell
45,257
-121,176
-73% -$3.93M 0.01% 1096
2022
Q1 		$6.02M Buy
166,433
+149,750
+898% +$5.14M 0.03% 572
2021
Q4 		$660K Buy
+16,683
New +$696K ﹤0.01% 1361
2021
Q2 		– Sell
-15,155
Closed -$498K – 1672
2021
Q1 		$498K Sell
15,155
-128,370
-89% -$4.83M ﹤0.01% 1183
2020
Q4 		$5.84M Sell
143,525
-39,109
-21% -$1.46M 0.05% 413
2020
Q3 		$6.69M Buy
182,634
+27,914
+18% +$1.01M 0.06% 364
2020
Q2 		$5.24M Buy
+154,720
New +$4.22M 0.06% 342

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Voloridge Investment Management's GMAB Position: Q1 2026 in Review

Voloridge Investment Management sold out of Genmab (GMAB) in Q1 2026, closing a stake of 84,302 shares — an estimated $2.6M sold.

Voloridge Investment Management first reported a position in GMAB in Q2 2020 and held it in 19 quarters. The position peaked at $25.7M in Q1 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Voloridge Investment Management reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 84,302 Genmab shares in Q1 2026, an estimated $2.6M.
  • Voloridge Investment Management first reported a position in Genmab in Q2 2020 and held it in 19 quarters.
  • Voloridge Investment Management's Genmab position peaked at $25.7M in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.